HOME >> MEDICINE >> NEWS
NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks

nue for up to seven years.

The research structure resulting from this competition will enable NIAID's Division of AIDS to more effectively respond to global research needs, including those of people of color, those who live in poverty, and women, all of whom are increasingly affected by the HIV/AIDS pandemic and continue to be under-represented in clinical research.

"We are pleased to be making this announcement on World AIDS Day," says Dr. Fauci, "as this year's World AIDS Day theme focuses on 'Women, Girls, HIV and AIDS'."

Each network leadership group selected as part of this competition will work with NIAID and other NIH Institutes on a focused research effort. To most effectively coordinate across disciplines, each network can address significant scientific questions in one or more of six priority research areas

  • Developing HIV vaccines
  • Translating research insights into therapeutic products to treat HIV disease
  • Optimizing clinical management of HIV/AIDS, including co-infections and other HIV-related conditions
  • Developing microbicides to prevent HIV acquisition and transmission
  • Preventing mother-to-child transmission of HIV
  • Developing other methods of HIV prevention

    The decision to revamp the clinical research structure emerged following extensive consultations with researchers, clinicians, community, nurses, advocates and people living with and at risk for HIV/AIDS. The new approach is designed to increase the efficiency, accountability and integration of NIAID's HIV/AIDS clinical research networks and enhance their capacity to effectively conduct vital clinical research, especially in resource-limited settings. Specifically, the new clinical research structure will

  • Maximize scientific opportunities by integrating and coordinating HIV/AIDS prevention, vaccine and therapeutic research and maintaining a flexible and responsive approach to emerg
    '"/>


  • Contact: NIAID Press Office
    niaidnews@niaid.nih.gov
    301-402-1663
    NIH/National Institute of Allergy and Infectious Diseases
    1-Dec-2004


    Page: 1 2 3

    Related medicine news :

    1. NIAID initiates trial of experimental avian flu vaccine
    2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
    3. NIAID begins enrolling volunteers for novel HIV vaccine study
    4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
    5. NIAID launches influenza genome sequencing project
    6. NIAID launches program to improve medical tools against emerging infectious diseases
    7. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
    8. NIAID rotavirus vaccine licensed for commercialization
    9. Second NIAID SARS vaccine candidate helps mice fend off SARS
    10. NIAID vaccine protects against SARS virus infection in mice
    11. NIAID Ebola vaccine enters human trial

    Post Your Comments:
    (Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
    (Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
    (Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
    (Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
    (Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
    Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
    (Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
    (Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
    (Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
    Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
    Cached News: